Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disease of the gastrointestinal tract, with increasing prevalence worldwide. IBD Ahead is an international educational program that aims to explore questions commonly raised by clinicians about various areas of IBD care and to consolidate available published evidence and expert opinion into a consensus for the optimization of IBD management. Given differences in the epidemiology, clinical and genetic characteristics, management, and prognosis of IBD between patients in Japan and the rest of the world, this statement was formulated as the result of literature reviews and discussions among Japanese experts as part of the IBD Ahead program to consolidate statements of factors for disease prognosis in IBD. Evidence levels were assigned to summary statements in the following categories: disease progression in CD and UC; surgery, hospitalization, intestinal failure, and permanent stoma in CD; acute severe UC; colectomy in UC; and colorectal carcinoma and dysplasia in IBD. The goal is that this statement can aid in the optimization of the treatment strategy for Japanese patients with IBD and help identify high-risk patients that require early intervention, to provide a better long-term prognosis in these patients.

Citations

Citations to this article as recorded by  

• Ear, Nose, and Throat Manifestations in Inflammatory Bowel Diseases: A Systematic Review of the Clinical Spectrum
  Eleni Litsou, Georgios Psychogios, Maria Saridi, Konstantinos H. Katsanos, Fotios Fousekis
  Medicina.2026; 62(5): 943.     CrossRef
• Precision medicine in inflammatory bowel diseases
  Ashwin N. Ananthakrishnan
  Intestinal Research.2024; 22(1): 8.     CrossRef
• Impact of Concomitant Prescriptions and Lifestyle Factors on the Initial Course of Newly Diagnosed Inflammatory Bowel Disease
  Hiromu Morikubo, Takayoshi Nagahama, Katsuhiko Nagai, Hajime Yamazaki, Taku Kobayashi
  Inflammatory Intestinal Diseases.2024; 9(1): 260.     CrossRef
• A Retrospective Cohort Study of Clinical Features and Treatment Patterns With Ustekinumab in Patients With Crohn Disease Utilizing a Health Care Database in Japan
  Yanfang Liu, Choo Hua Goh, Hong Qiu, Kuan-Chih Huang, Hsingwen Chung, Carine Saadoun
  Annals of Pharmacotherapy.2023; 57(9): 1053.     CrossRef
• Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis
  Kunio Asonuma, Taku Kobayashi, Masaru Nakano, Shintaro Sagami, Hiroki Kiyohara, Mao Matsubayashi, Hiromu Morikubo, Yusuke Miyatani, Shinji Okabayashi, Hajime Yamazaki, Yuichiro Kuroki, Toshifumi Hibi
  Inflammatory Bowel Diseases.2022; 28(2): 200.     CrossRef
• Intestinal cancer in patients with Crohn's disease: A systematic review and meta‐analysis
  Motoi Uchino, Hiroki Ikeuchi, Keisuke Hata, Tomohiro Minagawa, Yuki Horio, Ryuichi Kuwahara, Shiro Nakamura, Kenji Watanabe, Masayuki Saruta, Toshimitsu Fujii, Taku Kobayashi, Ken Sugimoto, Fumihito Hirai, Motohiro Esaki, Sakiko Hiraoka, Katsuyoshi Matsuo
  Journal of Gastroenterology and Hepatology.2021; 36(2): 329.     CrossRef
• MR-enterography in Crohn’s disease: what MRE mural parameters are associated to one-year therapeutic management outcome?
  Pier Paolo Mainenti, Fabiana Castiglione, Antonio Rispo, Ettore Laccetti, Salvatore Guarino, Valeria Romeo, Anna Testa, Leonardo Pace, Simone Maurea
  The British Journal of Radiology.2021;[Epub]     CrossRef
• Incidence and Outcomes of Perianal Disease in an Asian Population with Crohn’s Disease: A Nationwide Population-Based Study
  Eun Mi Song, Ho-Su Lee, Ye-Jee Kim, Eun Hye Oh, Nam Seok Ham, Jeongseok Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Jong Lyul Lee, Yong Sik Yoon, Chang Sik Yu, Suk-Kyun Yang
  Digestive Diseases and Sciences.2020; 65(4): 1189.     CrossRef
• Passion fruit (Passiflora edulis) leaf aqueous extract ameliorates intestinal epithelial barrier dysfunction and reverts inflammatory parameters in Caco-2 cells monolayer
  Mônica Cristina Lopes do Carmo, Isabela Mateus Martins, Ana Elisa Ramos Magalhães, Mário Roberto Maróstica Júnior, Juliana Alves Macedo
  Food Research International.2020; 133: 109162.     CrossRef
• Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study
  Toshifumi Hibi, Satoshi Motoya, Toshifumi Ashida, Souken Sai, Yukinori Sameshima, Shiro Nakamura, Atsuo Maemoto, Masahiro Nii, Barbara A Sullivan, Robert A. Gasser Jr, Yasuo Suzuki
  Intestinal Research.2019; 17(3): 375.     CrossRef

Citations

Citations to this article as recorded by  

• Genetic Determinants of Hematopoietic Toxicity Risk in Thai Pediatric Patients Undergoing 6‐Mercaptopurine Treatment
  Kanyarat Khaeso, Su‐on Chainansamit, Pitchayanan Kuwatjanakul, Patcharee Komvilaisak, Nontaya Nakkam, Kunanya Suwannaying, Suda Vannaprasaht, Areerat Dornsena, Wichittra Tassaneeyakul
  Clinical and Translational Science.2026;[Epub]     CrossRef
• Monogenic forms of inflammatory bowel disease: Genetic mechanisms, models, and clinical implications
  Amirhossein Ghorbanpour, Pejman Rohani, Shabnam Shahrokh, Georges Dimitrov, Mehdi Totonchi, Stefan Dimitrov
  Molecular Medicine.2026;[Epub]     CrossRef
• Comprehensive overview of the global pharmacogenetic and functional variability in NUDT15
  Yitian Zhou, Lukas M. Lauschke, Volker M. Lauschke
  Human Genomics.2026;[Epub]     CrossRef
• A case of rapidly progressive hair loss due to azathioprine, and the prevalence of NUDT15 variants among Japanese patients with autoimmune blistering diseases: A single‐center retrospective observational study
  Sho Katayama, Kentaro Izumi, Inkin Ujiie, Hideyuki Ujiie
  The Journal of Dermatology.2025; 52(2): 363.     CrossRef
• Comparative study on the pathogenesis of Crohn’s disease and ulcerative colitis
  Qi-Hang Yang, Chuang-Nian Zhang
  World Journal of Gastroenterology.2025;[Epub]     CrossRef
• Establishment of a novel predictive model for thiopurine-induced leucopenia based on the polymorphisms in the DNA-thioguanine nucleotide metabolite pathway in Chinese patients with inflammatory bowel disease
  Xia Zhu, Xue-ding Wang, Qiao-lan Xuan, Shao-xing Guan, Yan-pin Guan, Xiang Gao, Kang Chao, Min Huang
  Drug Metabolism and Disposition.2025; 53(8): 100119.     CrossRef
• Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study
  Motoki Makuuchi, Yoichi Kakuta, Junji Umeno, Toshimitsu Fujii, Tetsuya Takagawa, Takashi Ibuka, Miki Miura, Yu Sasaki, Sakuma Takahashi, Hiroshi Nakase, Hiroki Kiyohara, Keiichi Tominaga, Yosuke Shimodaira, Sakiko Hiraoka, Nobuhiro Ueno, Shunichi Yanai, T
  Journal of Gastroenterology.2024; 59(6): 468.     CrossRef
• Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn’s disease: a Korean nationwide population-based study
  Yu Kyung Jun, Eunjeong Ji, Hye Ran Yang, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Hyuk Yoon
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• A systematic review of aspects of NUDT15 pharmacogenomic variants and thiopurine-induced myelosuppression
  Rachel Palmer, Jaime Peters
  RPS Pharmacy and Pharmacology Reports.2024;[Epub]     CrossRef
• m6A modification in inflammatory bowel disease provides new insights into clinical applications
  Jiamin Zhang, Bimei Song, Yue Zeng, Chao Xu, Liang Gao, Yan Guo, Jingbo Liu
  Biomedicine & Pharmacotherapy.2023; 159: 114298.     CrossRef
• Targeting FTO by Dac51 contributes to attenuating DSS-induced colitis
  Chunyan Peng, Chang Zheng, Fan Zhou, Ying Xie, Lei Wang, Deyan Chen, Xiaoqi Zhang
  International Immunopharmacology.2023; 116: 109789.     CrossRef
• Single-Nucleotide Polymorphisms, c.415C > T (Arg139Cys) and c.416G > A (Arg139His), in the NUDT15 Gene Are Associated with Thiopurine-Induced Leukopenia
  Tetsuichiro Isono, Daiki Hira, Yoshito Ikeda, Masahiro Kawahara, Satoshi Noda, Atsushi Nishida, Osamu Inatomi, Noriki Fujimoto, Akira Andoh, Tomohiro Terada, Shin-ya Morita
  Biological and Pharmaceutical Bulletin.2023; 46(3): 412.     CrossRef
• Evaluation of FTO polymorphism in 6-mercaptopurine related intolerance in children with acute lymphoblastic leukemia
  Minu Singh, Divya Bhaskar, Prateek Bhatia, Rozy Thakur, Pankaj Sharma, Deepak Bansal, Richa Jain, Amita Trehan
  Cancer Chemotherapy and Pharmacology.2023; 92(1): 51.     CrossRef
• Time to incorporate preemptive NUDT15 testing before starting thiopurines in inflammatory bowel disease in Asia and beyond: a review
  Devendra Desai, Anuraag Jena, Vishal Sharma, Toshifumi Hibi
  Expert Review of Clinical Pharmacology.2023; 16(7): 643.     CrossRef
• Safety and efficacy of personalized versus standard initial dosing of thiopurines: Systematic review and meta-analysis of randomized trials
  Anuraag Jena, Chhagan L Birda, Arup Choudhury, Vishal Sharma
  Expert Opinion on Drug Safety.2023; 22(12): 1253.     CrossRef
• Comparative assessment of anti-cancer drugs against NUDT15 variants to prevent leucopenia side effect in leukemia patients
  V. Janakiraman, M. Sudhan, Khalaf F. Alsharif, Ibrahim F. Halawani, Shiek S.S.J. Ahmed, Shankargouda Patil
  Journal of Genetic Engineering and Biotechnology.2023; 21(1): 82.     CrossRef
• Association of NUDT15 gene polymorphism with adverse reaction, treatment efficacy, and dose of 6-mercaptopurine in patients with acute lymphoblastic leukemia: a systematic review and meta-analysis
  Shan Du, Xuefei Huang, Xia He, Mian Mao, Min Chen, Rong Zhang, Huikai Shao, Ziyan Lv, Xinxia Liu, Junlan Chuan
  Haematologica.2023; 109(4): 1053.     CrossRef
• A rare case of Azathioprine-induced leukopenia in an European woman
  Wautier Séverine, De Koninck Xavier, Coche Jean-Charles
  Acta Clinica Belgica.2022; 77(1): 163.     CrossRef
• NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine
  Kanyarat Khaeso, Patcharee Komvilaisak, Su-on Chainansamit, Nontaya Nakkam, Kunanya Suwannaying, Pitchayanan Kuwatjanakul, Keiko Hikino, Areerat Dornsena, Sirimas Kanjanawart, Napat Laoaroon, Suda Vannaprasaht, Takeshi Taketani, Wichittra Tassaneeyakul
  Drug Metabolism and Pharmacokinetics.2022; 43: 100436.     CrossRef
• Nudix Hydroxylase 15 Mutations Strongly Predict Thiopurine-Induced Leukopenia Across Different Asian Ethnicities: Implications for Screening in a Diverse Population
  Xin-Hui Khoo, Shin Yee Wong, Nik Razima Wan Ibrahim, Ruey Terng Ng, Kee Seang Chew, Way Seah Lee, Zhi Qin Wong, Raja Affend Raja Ali, Shahreedhan Shahrani, Alex Hwong-Ruey Leow, Ida Normiha Hilmi
  Frontiers in Medicine.2022;[Epub]     CrossRef
• NUDT15Genotyping in Thiopurine Drug Therapy
  Jong Kwon Lee, Rihwa Choi, Soo-Youn Lee
  Laboratory Medicine Online.2022; 12(4): 217.     CrossRef
• Personalized medicine to implementation science: Thiopurines set for the leap
  Vishal Sharma, Saurabh Kedia, Vineet Ahuja
  JGH Open.2022; 6(10): 651.     CrossRef
• Pharmacogenetic determinants of thiopurines in an Indian cohort
  Shaik Mohammad Naushad, Mekala Janaki Ramaiah, Vijay Kumar Kutala, Tajamul Hussain, Salman A. Alrokayan
  Pharmacological Reports.2021; 73(1): 278.     CrossRef
• The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
  Xinwei Xu, Jintu Huang, Dickson Kofi Wiredu Ocansey, Yuxuan Xia, Zihan Zhao, Zhiwei Xu, Yongmin Yan, Xu Zhang, Fei Mao
  Journal of Inflammation Research.2021; Volume 14: 3289.     CrossRef
• Importance of NUDT15 Polymorphisms in Thiopurine Treatments
  Yoichi Tanaka, Yoshiro Saito
  Journal of Personalized Medicine.2021; 11(8): 778.     CrossRef
• Randomised clinical trial: dose optimising strategy by NUDT15 genotyping reduces leucopenia during thiopurine treatment of Crohn's disease
  Kang Chao, Yibiao Huang, Xia Zhu, Jian Tang, Xueding Wang, Lang Lin, Huili Guo, Caibin Zhang, Miao Li, Qingfan Yang, Jie Huang, Lingna Ye, Pinjin Hu, Min Huang, Qian Cao, Xiang Gao
  Alimentary Pharmacology & Therapeutics.2021; 54(9): 1124.     CrossRef
• Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
  Kanyarat Khaeso, Sariya Udayachalerm, Patcharee Komvilaisak, Su-on Chainansamit, Kunanya Suwannaying, Napat Laoaroon, Pitchayanan Kuwatjanakul, Nontaya Nakkam, Chonlaphat Sukasem, Apichaya Puangpetch, Wichittra Tassaneeyakul, Nathorn Chaiyakunapruk
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• High-resolution melt analysis enables simple genotyping of complicated polymorphisms of codon 18 rendering the NUDT15 diplotype
  Yoichi Kakuta, Yasuhiro Izumiyama, Daisuke Okamoto, Takeru Nakano, Ryo Ichikawa, Takeo Naito, Rintaro Moroi, Masatake Kuroha, Yoshitake Kanazawa, Tomoya Kimura, Hisashi Shiga, Hisaaki Kudo, Naoko Minegishi, Yosuke Kawai, Katsushi Tokunaga, Masao Nagasaki,
  Journal of Gastroenterology.2020; 55(1): 67.     CrossRef
• An intronic FTO variant rs16952570 confers protection against thiopurine-induced myelotoxicities in multiethnic Asian IBD patients
  Sylvia Chen, Wei Zhi Tan, Natalia Sutiman, Cindy Lim, Sze Sing Lee, Wai Fook Leong, Madeline Tjai, Chunyan Wang, Chris San Choon Kong, Sai Wei Chuah, Brian John Schwender, Webber Chan, Hang Hock Shim, Wee Chian Lim, Chiea Chuen Khor, Khoon Lin Ling, Balra
  The Pharmacogenomics Journal.2020; 20(3): 505.     CrossRef
• Precision therapy of 6‐mercaptopurine in Chinese children with acute lymphoblastic leukaemia
  Yue Zhou, Li Wang, Xiao‐Ying Zhai, Li Wen, Fang Tang, Fan Yang, Xi‐Ting Liu, Lei Dong, Li‐Juan Zhi, Hai‐Yan Shi, Guo‐Xiang Hao, Yi Zheng, Evelyne Jacqz‐Aigrain, Tian‐You Wang, Wei Zhao
  British Journal of Clinical Pharmacology.2020; 86(8): 1519.     CrossRef
• NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
  Katsuyoshi Matsuoka
  Intestinal Research.2020; 18(3): 275.     CrossRef
• Long‐term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine
  Shintaro Akiyama, Katsuyoshi Matsuoka, Kyoko Fukuda, Shunsuke Hamada, Mikiko Shimizu, Kosaku Nanki, Shinta Mizuno, Hiroki Kiyohara, Mari Arai, Shinya Sugimoto, Yasushi Iwao, Haruhiko Ogata, Tadakazu Hisamatsu, Makoto Naganuma, Maiko Motobayashi, Kohei Suz
  Journal of Gastroenterology and Hepatology.2019; 34(10): 1751.     CrossRef
• Systematic review with meta‐analysis: risk factors for thiopurine‐induced leukopenia in IBD
  Sara van Gennep, Kadère Konté, Berrie Meijer, Martijn W. Heymans, Geert R. D’Haens, Mark Löwenberg, Nanne K. H. de Boer
  Alimentary Pharmacology & Therapeutics.2019; 50(5): 484.     CrossRef
• Mycophenolate mofetil and prednisolone for cerebral sinus venous thrombosis with Behcet's disease
  Shintaro Terashita, Tomomi Tanaka, Hiromichi Taneichi, Yuichi Adachi, Masaaki Mori
  Pediatrics International.2019; 61(9): 920.     CrossRef
• Behcet's Disease With Cerebral Artery Infarction Caused by Cerebral Arteritis as an Early Symptom Only With Elevated Interleukin-8
  Hao Yin, Yun Song, Meimei Zheng, Ju Han, Jiyou Tang
  Frontiers in Neurology.2019;[Epub]     CrossRef
• Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping
  Yoichi Kakuta, Yoshitaka Kinouchi, Tooru Shimosegawa
  Journal of Gastroenterology.2018; 53(2): 172.     CrossRef
• NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study
  Yoichi Kakuta, Yosuke Kawai, Daisuke Okamoto, Tetsuya Takagawa, Kentaro Ikeya, Hirotake Sakuraba, Atsushi Nishida, Shoko Nakagawa, Miki Miura, Takahiko Toyonaga, Kei Onodera, Masaru Shinozaki, Yoh Ishiguro, Shinta Mizuno, Masahiro Takahara, Shunichi Yanai
  Journal of Gastroenterology.2018; 53(9): 1065.     CrossRef
• Severe thiopurine‐induced leukocytopenia and hair loss in Japanese patients with defective NUDT15 variant: Retrospective case–control study
  Mari Kishibe, Hiroyoshi Nozaki, Mizue Fujii, Shin Iinuma, Sawa Ohtsubo, Satomi Igawa, Kyoko Kanno, Masaru Honma, Kan Kishibe, Kensaku Okamoto, Akemi Ishida‐Yamamoto
  The Journal of Dermatology.2018; 45(10): 1160.     CrossRef
• Diagnostic accuracy of NUDT15 gene variants for thiopurine-induced leukopenia: a systematic review and meta-analysis
  Sarah Cargnin, Armando A. Genazzani, Pier Luigi Canonico, Salvatore Terrazzino
  Pharmacological Research.2018; 135: 102.     CrossRef
• A single‐center experience with methotrexate in the treatment of Chinese Crohn’s disease patients
  Tian Rong Wang, Yu Qi Qiao, Duo Wu Zou, Zhi Hua Ran
  Journal of Digestive Diseases.2018; 19(12): 753.     CrossRef